Dr. Orest Lastow is the co-founder and CEO of Iconovo AB.
He is responsible for the development of Iconovo’s inhalation device platforms and formulations and has over 40 patents and patent applications. He is also the founder and previous CEO of Medicon Valley Inhalation Consortium, MVIC AB.
Before that Orest was with AstraZeneca for over 15 years.
Orest received a M.Sc. in Engineering Physics and a Licentiate of Engineering degree in Aerosol Science from Lund University. He has also a Ph.D. in electrohydrodynamic atomization from Brunel University. His expertise is in device development, electrostatics, Computational Fluid Dynamics (CFD), aerosol science and inhalation technology. He is the author behind a textbook on EHD atomization, several journal publications and book contributions.
He is frequently invited to speak at conferences and teaches aerosol drug delivery at Lund University, Copenhagen University and Shenyang University.
Orest is a co-author of the Aerosol drug delivery device design verification standard (ISO 20072).